The combination of IκB kinase β inhibitor and everolimus modulates expression of interleukin-10 in human T-cell lymphotropic virus type-1-infected T cells

Immunology

Volumn 138, Issue 3, 2013, Pages 216-227

  Nishioka, Chie ^a,b   Ikezoe, Takayuki ^a   Yang, Jing ^a   Udaka, Keiko ^a   Yokoyama, Akihito ^a  

^a KOCHI UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

Adult T cell leukaemia lymphoma; Bay11 7082; Everolimus; Human T cell lymphotropic virus type 1 infected T cells; Interleukin 10

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; EVEROLIMUS; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; T LYMPHOCYTE;

ANTINEOPLASTIC AGENTS; CELL LINE; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HTLV-I INFECTIONS; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-10; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; NITRILES; SIGNAL TRANSDUCTION; SIROLIMUS; STAT3 TRANSCRIPTION FACTOR; SULFONES; T-LYMPHOCYTES; TOR SERINE-THREONINE KINASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84873323853     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12035     Document Type: Article

References (30)

1. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78:6476-80.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79:2031-5.
3. Mori N, Gill PS, Mougdil T, Murakami S, Eto S, Prager D. Interleukin-10 gene expression in adult T-cell leukemia. Blood 1996; 88:1035-45.
4. Niitsu Y, Urushizaki Y, Koshida Y, Terui K, Mahara K, Kohgo Y, Urushizaki I. Expression of TGF-β gene in adult T cell leukemia. Blood 1988; 71:263-6.
5. Karube K, Ohshima K, Tsuchiya T et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br J Haematol 2004; 126:81-4.
6. Yano H, Ishida T, Inagaki A et al. Regulatory T-cell function of adult T-cell leukemia/lymphoma cells. Int J Cancer 2007; 120:2052-7.
7. + adult T cell leukemia cells. Int Immunol 2006; 18:269-77.
8. Roncador G, Garcia JF, Garcia JF et al. FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma. Leukemia 2005; 19:2247-53.
9. Gorelik L, Flavell RA. Transforming growth factor-β in T-cell biology. Nat Rev Immunol 2002; 2:46-53.
10. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172:5149-53.
11. + regulatory T cells. J Exp Med 2005; 201:1061-7.
12. Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity 2006; 25:441-54.
13. + cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol 1991; 3:761-7.
14. Makino M, Wakamatsu S, Shimokubo S, Arima N, Baba M. Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia. Virology 2000; 274:140-8.
15. Lappas M, Permezel M, Georgiou HM, Rice GE. Nuclear factor κB regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 2002; 67:668-73.
16. Russo MP, Schwabe RF, Sartor RB, Jobin C. NF-κB-inducing kinase restores defective IκB kinase activity and NF-κB signaling in intestinal epithelial cells. Cell Signal 2004; 16:741-50.
17. Mori N, Yamada Y, Ikeda S et al. Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002; 100:1828-34.
18. Ikezoe T, Nishioka C, Bandobashi K et al. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leuk Res 2007; 3:673-82.
19. Säemann MD, Haidinger M, Hecking M, Hörl WH, Weichhart T. The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant 2009; 9:2655-61.
20. Nishioka C, Ikezoe T, Jing Y, Umezawa K, Yokoyama A. DHMEQ, a novel nuclear factor-κB inhibitor, induces selective depletion of alloreactive or phytohaemagglutinin-stimulated peripheral blood mononuclear cells, decreases production of T helper type 1 cytokines, and blocks maturation of dendritic cells. Immunology 2008; 124:198-205.
21. Nishioka C, Ikezoe T, Yang J, Yokoyama A. Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene. Leukemia 2010; 24:1631-40.
22. Taga K, Mostowski H, Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood 1993; 81:2964-71.
23. Makino M, Shimokubo S, Wakamatsu SI, Izumo S, Baba M. The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J Virol 1999; 73:4575-81.
24. Baker AK, Wang R, Mackman N, Luyendyk JP. Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-α expression in macrophages by reducing IL-10 expression. Mol Immunol 2009; 46:2249-55.
25. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-65.
26. + T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma. Leukemia 2004; 18:126-32.
27. Jiang Q, Weiss JM, Back T, Chan T, Ortaldo JR, Guichard S, Wiltrout RH. mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment. Cancer Res 2011; 71:4074-84.
28. Chang CH, Furue M, Tamaki K. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by interleukin-10. Eur J Immunol 1995; 25:394-8.
29. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151:1224-34.
30. Honda K, Sakaguchi S, Nakajima C et al. Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci USA 2003; 100:10872-7.